# Sanofi India Ltd (SANOFI)
> Exchange: NSE | Sector: Pharma | ISIN: INE058A01010

## Price
Current Price: ₹3181.9
Day Change: +0.59%
52W High: ₹6410
52W Low: ₹3160
Market Cap: ₹7,363 Cr

## Valuation
P/E: 23.77
P/B: 9.83
EPS: ₹134.51
Book Value: ₹325.31
Dividend Yield: 0%

## Returns
1Y Return: -30.95%

## Profitability
ROE: 0%
ROCE: 413.1%
Debt/Equity: 0.02
Revenue Growth: -11.9%
Profit Growth: -14.1%
EBITDA Margin: 25.81%
Operating Margin: 28.33%

## About
Sanofi India Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - General
Sub Industry: Unknown

## Business Model
Overview: Sanofi India Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Announcement: Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Data Freshness
Quote Updated: 2026-05-25T14:00:11.436Z
Price History Updated: 2026-05-25T05:31:09.685Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:31:09.685Z
Quant Updated: 2026-05-25T05:31:09.685Z
Sentiment Updated: 2026-05-25T05:31:09.685Z
Financials Status: current
Financials Updated: 2026-05-18T11:32:11.267Z
Financials Last Attempt: 2026-05-18T11:32:11.267Z
Financials Provider Tried: yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (Dec 2024)
Revenue: ₹1996 Cr
Operating Profit: ₹488 Cr (OPM 24%)
Net Profit: ₹603 Cr
Tax: ₹767 Cr

## Balance Sheet (Dec 2024)
Total Assets: ₹1715 Cr
Total Liabilities: ₹1715 Cr
Borrowings: ₹19 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Deepak  Arora, Country Lead, MD & GM of Pharma
- Rachid  Ayari, CFO & Whole Time Director
- Mahadev  Gawade, Additional Whole-time Director & Site Head - Goa
- M. K. Narayanaswamy A.I.C.W.A., B.Com., Senior Director of Accounting & Taxation
- Sudipta  Chakraborty, Head of Legal & Whole-time Director

---
Source: rupiya.io/stocks/sanofi
Disclaimer: For research and education only. Not investment advice.